merck worlds largest drugs group today reveal developing new compound treat enlarged prostate condition affects 50 per cent men 60 70 per cent 70 more 10m americans affected disease dr roy vagelos chairman chief executive dr edward scolnick president merck research laboratories present analysts early clinical data new compound showing effective the new drug successfully developed prove important element mercks growing prostate franchise merck already developed compound called proscar treat condition also known benign prostatic hyperplasia however drug struggled generate expected sales specialists concerned drugs effectiveness although admit safety profile excellent the condition involves enlarged prostate obstructing flow urine bladder penis causing need frequent urgent urination normally treated surgery